Novo Nordisk A/S: 23% - -- 4 , REDEFINE 4 was an 84-week trial investigating CagriSema (a fixed dose combination of cagrilintide 2.4 mg and semaglutide 2.4 mg) compared to tirzepatide 15 mg, both administered once-weekly and subcutaneously
Think about it this way: a single speculative injection at a private clinic could set you back 50
For a 220-pound person, it represents roughly 13 additional pounds of weight loss
Although this won't happen from just a few cups of tea daily, there have been recent cases where habitually drinking extremely large amounts of tea has caused "fluorosis" causing bone pain and even tooth loss
Compared to placebo, B-vitamin supplementation in these older subjects also improved a measure of executive function, a secondary outcome of the trial (93)
The condition typically develops gradually, starting as mild stiffness that resolves with warmup, then progressing to persistent pain that limits training capacity